Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

Study reveals multiple high-risk genetic changes predict worse multiple myeloma outcomes across all treatments.

In spite of recent advances in the management of multiple myeloma, cure has been elusive, with efforts to improve long-term ...

Researchers sought to determine whether CAR-T therapy with ide-cel would be effective in patients with triple-class–exposed relapsed/refractory MM.

A couple facing a terminal multiple myeloma diagnosis finds renewed hope through innovative immunotherapy, transforming blood ...

Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood cells that produce infection-fighting antibodies. Multiple myeloma is not hereditary, meaning it is not passed ...

Saad Usmani, Chief of MSK's Myeloma Service, says there are far more treatment options for multiple myeloma today compared with just 20 years ago. Note: This story was originally published in 2022 and ...

In the phase 3, randomized CARTITUDE-4 trial involving patients with lenalidomide-refractory multiple myeloma who had received one to three previous lines of therapy, cilta-cel significantly ...

Those monitoring will include checking for myeloma markers, blood numbers, et cetera, that might indicate relapse. Being in close communication with the treating doctors. If you have unusual ...

Using multiple mouse models of myeloma and mixed ... A CML cell line, K562, negative for myeloma markers was induced to express either CS1 (CS1-K562) or BCMA (BCMA-K562). After confirming ...

The flood-ravaged northern sections of the Bruce Highway could be out of action for at least a week, predicts Blenners Transport boss Les Blennerhassett. Speaking to the Cairns Post, Blennherhassett ...